Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838133 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
A Phase 2 study, sponsored by Taiwan Liposome Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT03838133: Completed Phase 2 study, sponsored by Taiwan Liposome Company.
NCT03838133 is a Phase 2 study that has completed, run by Taiwan Liposome Company. The registered enrollment target is 150 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03838133, a Phase 2 study, has completed, sponsored by Taiwan Liposome Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This is a Phase 2, randomized, double-blind, 2-part comparator- and placebo-controlled study to evaluate the safety, PK, and efficacy of TLC590 via a single infiltrative local administration in adult subjects following bunionectomy.
Primary Outcome
AUC of numerical pain rating scale (NPRS-R) following bunionectomy surgery
Interventions
- DRUG Bupivacaine
- DRUG TLC590
- DRUG Normal Saline
- DRUG Naropin®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2020-03-31 |
| Phase | Phase 2 |
What the finished NCT03838133 record still lists
NCT03838133 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT03838133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03838133 about?
NCT03838133 is a clinical study titled "A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy". This is a Phase 2, randomized, double-blind, 2-part comparator- and placebo-controlled study to evaluate the safety, PK, and efficacy of TLC590 via a single infiltrative local administration in adult subjects following bunionectomy.
What is the current status of trial NCT03838133?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2019-03-05. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT03838133?
The interventions under investigation include: Bupivacaine (DRUG), TLC590 (DRUG), Normal Saline (DRUG), Naropin® (DRUG).
Who is sponsoring clinical trial NCT03838133?
This trial is sponsored by Taiwan Liposome Company, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03838133's enrollment target sits among peer trials
150 455th of 2000 higher than 1,510 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI